CNS Pharmaceuticals (CNSP) News Today $0.11 +0.01 (+5.41%) (As of 12/26/2024 05:41 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period CNS Pharmaceuticals (NASDAQ: CNSP) to Present Berubicin Trial Update at Society for Neuro-Oncology Annual MeetingNovember 20, 2024 | theglobeandmail.comCNS Pharmaceuticals sees cash runway through 2Q25November 16, 2024 | markets.businessinsider.comCNS Pharmaceuticals: Financial Results and Strategic MovesNovember 16, 2024 | markets.businessinsider.comCNS Pharmaceuticals (NASDAQ: CNSP) Highlights Berubicin’s Potential During KOL Connect EventNovember 5, 2024 | theglobeandmail.comCNS Pharmaceuticals (NASDAQ: CNSP) Secures $3 Million in Registered Direct OfferingOctober 25, 2024 | theglobeandmail.comWhy CNS Pharmaceuticals (CNSP) Stock Is Up 86%October 23, 2024 | benzinga.comCNS Pharma (NASDAQ:CNSP) Stock, Short Interest ReportOctober 6, 2024 | benzinga.comCNS Pharma (NASDAQ:CNSP) Stock, Insider Trading ActivityOctober 4, 2024 | benzinga.comCNS Pharmaceuticals, Inc.: CNS Pharmaceuticals to Present at the 24th Annual Biotech in Europe ForumSeptember 23, 2024 | finanznachrichten.deBioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation at the 24th Annual Biotech in Europe ForumSeptember 23, 2024 | msn.comCNS Pharmaceuticals, Inc.: CNS Pharmaceuticals Regains Compliance with Nasdaq Equity RequirementSeptember 12, 2024 | finanznachrichten.deMaxim Group Upgrades CNS Pharmaceuticals (CNSP)September 11, 2024 | nasdaq.comCNS Pharmaceuticals (NASDAQ: CNSP) CEO Slated to Present at H.C. Wainwright ConferenceSeptember 6, 2024 | theglobeandmail.comCNS Pharmaceuticals (NASDAQ: CNSP) CEO Featured in Latest BioMedWire Podcast EpisodeSeptember 5, 2024 | theglobeandmail.comBioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Featured in Latest BioMedWire Podcast EpisodeSeptember 3, 2024 | msn.comIBN Announces Latest Episode of The BioMedWire Podcast featuring John Climaco, CEO of CNS Pharmaceuticals Inc.September 3, 2024 | globenewswire.comCNS Pharmaceuticals, Inc.: CNS Pharmaceuticals to Participate in at LIVE! with Webull Corporate Connect: Virtual Biotech Investment WebinarAugust 29, 2024 | finanznachrichten.deBioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment WebinarAugust 27, 2024 | msn.comCNS Pharmaceuticals (NASDAQ: CNSP) CEO to be Featured in Virtual Investor CEO Connect SegmentAugust 24, 2024 | theglobeandmail.comBioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Featured in Upcoming Virtual Investor CEO Connect SegmentAugust 22, 2024 | msn.comCNS Pharma (NASDAQ:CNSP) Stock Quotes, Forecast and News SummaryAugust 11, 2024 | benzinga.comCNS Pharmaceuticals in-licenses TPI 287 for GBM treatmentAugust 1, 2024 | uk.investing.comCNS Pharmaceuticals (NASDAQ: CNSP) Inks Exclusive License in ‘Transformational’ Step to Treating GBMJuly 30, 2024 | theglobeandmail.comWhat's Going On With CNS Pharmaceuticals Stock Tuesday?July 30, 2024 | msn.comWhy Is CNS Pharmaceuticals (CNSP) Stock Down 69% Today?July 30, 2024 | investorplace.comCNS Pharmaceuticals Stock Was Volatile Wednesday: What You Need To KnowJuly 3, 2024 | benzinga.comCNS Pharmaceuticals (NASDAQ: CNSP) CEO to Present at 2024 Healthcare Company ShowcaseMay 22, 2024 | theglobeandmail.comCNSP Stock Earnings: CNS Pharmaceuticals Reported Results for Q1 2024May 16, 2024 | investorplace.comCNS Pharmaceuticals, Inc.: CNS Pharmaceuticals Reports First Quarter 2024 Financial ResultsMay 16, 2024 | finanznachrichten.deCNS Pharmaceuticals (NASDAQ: CNSP) CEO to Present at LSX World Congress 2024April 25, 2024 | theglobeandmail.comCNS Pharmaceuticals (NASDAQ: CNSP) Releases FY 2023 Financial Report, Corporate UpdateApril 4, 2024 | theglobeandmail.comCNS Pharma Stock (NASDAQ:CNSP), Earnings Estimates, EPS, and RevenueApril 3, 2024 | benzinga.comCNSP Stock Earnings: CNS Pharmaceuticals Reported Results for Q4 2023April 2, 2024 | investorplace.comCNS Pharmaceuticals (NASDAQ: CNSP) Welcomes Proven Commercialization Leader to BoardMarch 20, 2024 | theglobeandmail.comCns Pharmaceuticals Inc (CNSP)February 9, 2024 | investing.comCNS Pharmaceuticals Launches Public Offering for Trial FundingFebruary 3, 2024 | msn.comCNS Pharmaceuticals (NASDAQ: CNSP) Releases Info on $4M Public Offering PricingJanuary 30, 2024 | theglobeandmail.comCNS Pharmaceuticals, Inc.: CNS Pharmaceuticals Announces Pricing of $4.0 Million Public OfferingJanuary 29, 2024 | finanznachrichten.deCNS Pharmaceuticals Announces Pricing of $4.0 Million Public OfferingJanuary 29, 2024 | finance.yahoo.comCNS Pharmaceuticals (NASDAQ: CNSP) Names Seasoned Biotech Leader to Board of DirectorsJanuary 19, 2024 | theglobeandmail.comCNS Pharmaceuticals, Inc.: Biotech Commercialization Leader, Amy Mahery, to Join CNS Pharmaceuticals Board of DirectorsJanuary 18, 2024 | finanznachrichten.deBiotech Commercialization Leader, Amy Mahery, to Join CNS Pharmaceuticals Board of DirectorsJanuary 18, 2024 | finance.yahoo.comCNS Pharmaceuticals Achieves Completion of Planned Enrollment in Potentially Pivotal Study of Berubicin for the Treatment of Glioblastoma Multiforme (GBM)January 17, 2024 | finance.yahoo.comCNSP CNS Pharmaceuticals, Inc.January 6, 2024 | seekingalpha.comCNS Pharmaceuticals Announces Successful Interim Analysis of Efficacy and Safety Data in Potentially Pivotal Study of BerubicinDecember 18, 2023 | finance.yahoo.comCNS Pharmaceuticals Inc Ordinary SharesDecember 14, 2023 | morningstar.comCNS Pharmaceuticals files to sell 3.81M shares of common stockDecember 8, 2023 | msn.comHow CNS Pharmaceuticals Is Taking A Different Approach To Find A Treatment For Glioblastoma, A Cancer With A Poor Prognosis And No CureDecember 6, 2023 | finance.yahoo.comCNS Pharmaceuticals (NASDAQ: CNSP) Presents Updated Safety Data from Ongoing Potentially Pivotal Study Evaluating Berubicin in Advance of the Pre-Planned Interim Analysis of EfficacyNovember 22, 2023 | finance.yahoo.comCNS Pharmaceuticals files to sell 3.76M shares of common stock for holdersNovember 21, 2023 | msn.com Get CNS Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CNSP and its competitors with MarketBeat's FREE daily newsletter. Email Address How Low-Cost Stocks Generate Monthly Income (Ad)Are you ready to transform your investment strategy and generate a steady monthly income? We’re excited to offer you our exclusive report, "Options Trading Strategy: 2 (Surprisingly) Low-Cost Stocks Primed for Generating Monthly Income," FREE! 👉 Yes, I Want the Free Report! 👈 CNSP Media Mentions By Week CNSP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CNSP News Sentiment▼0.940.60▲Average Medical News Sentiment CNSP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CNSP Articles This Week▼30▲CNSP Articles Average Week Get CNS Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CNSP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CMMB News Today CVKD News Today NKGN News Today MTEX News Today IBIO News Today NNVC News Today EQ News Today CTXR News Today PULM News Today GOVX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CNSP) was last updated on 12/27/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CNS Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CNS Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
